CFN Media

November 22, 2016 09:00 ET

Latin America Embraces Hemp-based CBD Oil -- CFN Media

SEATTLE, WA--(Marketwired - Nov 22, 2016) -  CFN Media Group, the leading creative agency and digital media network dedicated to legal cannabis, announces the publication of an article discussing the growing legal acceptance throughout South and Central America of cannabinoid-based medicines, and the leading role that Medical Marijuana Inc. (OTC PINK: MJNA) plays throughout the region.

As slow as the United States might be in realizing the medical benefits of cannabidiol (CBD), companies like Medical Marijuana Inc. have demonstrated they are on the forefront of research, production and distribution of legal cannabis products. Latin American countries have taken a much more progressive stance in endorsing such products and politicians worldwide are quickly realizing that legalizing marijuana could reduce crime and help patients suffering from a variety of conditions. With the global tide turning, this progression will create significant opportunities for companies operating in the burgeoning Latin American cannabis industry.

Mexico, Chile, Brazil, Colombia and Uruguay have all recently legalized, or announced the intention to legalize, some form of cannabis use. In February 2016 Mexico's regulatory authority, COFEPRIS, approved the legal import of Real Scientific Hemp Oil-X™ (MJNA's product) for two young girls suffering from severe epilepsy and the program soon expanded to all qualifying citizens with refractory epilepsy.

Currently, the Brazilian government has approved the import of hemp-based CBD oils for epilepsy, Parkinson's disease, and chronic pain, including migraine headaches. Patients with a doctor's prescription and approved import documentation can legally purchase Real Scientific Hemp Oil™ products from HempMeds Brazil - an affiliate of Medical Marijuana Inc.

Medical Marijuana Inc. also provides shareholders with exposure to its other portfolio companies like HempMeds, Dixie Botanicals, Kannaway and CanChew Biotechnologies. Further, the company has invested into two upcoming early-stage biotech enterprises, including AXIM Biotechnologies where MJNA owns a 45% stake.

The company looks forward to leveraging this experience in the United States as cannabinoids become more widely accepted. While the FDA doesn't allow specific medical claims to be made, researchers have demonstrated a wide variety of potential benefits for cannabinoids across conditions ranging from Alzheimer's disease to certain types of cancers. The ongoing progress made by researchers could eventually make way for these kinds of claims to be made.

Follow the link to read the full article:

Learn how to become a CFN Media featured company, brand or entrepreneur:

Download the CFN Media iOS mobile app to access the world of cannabis from your smart phone:

Or visit our homepage and enter your mobile number under the Apple App Store logo to receive a download link text on your iPhone:

About CFN Media

CFN Media (CannabisFN) is the leading creative agency and media network dedicated to legal cannabis. We help marijuana businesses attract investors, customers (B2B, B2C), capital, and media visibility. Private and public marijuana companies and brands in the US and Canada rely on CFN Media to grow and succeed.

About Medical Marijuana Inc.
Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally friendly, economically sustainable businesses, while increasing shareholder value.

For details on Medical Marijuana, Inc.'s portfolio and investment companies, visit

To see Medical Marijuana, Inc.'s video statement, click here
Shareholders are also encouraged to visit the Medical Marijuana, Inc. Shop for discounted products.


Except for the historical information presented herein, matters discussed in this release contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. Emerging Growth LLC, which owns CFN Media and, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. Emerging Growth LLC may from time to time have a position in the securities mentioned herein and may increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice. Emerging Growth LLC may be compensated for its services in the form of cash-based compensation or equity securities in the companies it writes about, or a combination of the two. For full disclosure please visit:

Contact Information